Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Cumulative Translation Adjustments
Beginning balance (in shares) at Dec. 31, 2022			74,567
Beginning balance at Dec. 31, 2022	$ 28,672	$ (29)	$ 74	$ 214,094	$ (185,493)	$ (29)	$ (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock (in shares)			343
Issuance of restricted stock	1		$ 1
Share-based compensation	3,714			3,714
Translation adjustment	2						2
Net Income (Loss)	(5,052)				(5,052)
Ending balance (in shares) at Sep. 30, 2023			74,910
Ending balance at Sep. 30, 2023	27,308		$ 75	217,808	(190,574)		(1)
Beginning balance (in shares) at Jun. 30, 2023			74,856
Beginning balance at Jun. 30, 2023	27,150		$ 75	216,691	(189,615)		(1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock (in shares)			54
Issuance of restricted stock	0
Share-based compensation	1,117			1,117
Translation adjustment	0
Net Income (Loss)	(959)				(959)
Ending balance (in shares) at Sep. 30, 2023			74,910
Ending balance at Sep. 30, 2023	27,308		$ 75	217,808	(190,574)		(1)
Beginning balance (in shares) at Dec. 31, 2023			74,981
Beginning balance at Dec. 31, 2023	28,456	$ 0	$ 75	218,845	(190,460)		(4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock resulting from the exercise of stock options (in shares)			768
Issuance of common stock resulting from the exercise of stock options	1,641		$ 1	1,640
Issuance of restricted stock (in shares)			253
Issuance of restricted stock	0
Share-based compensation (in shares)			25
Share-based compensation	2,904			2,904
Translation adjustment	(3)						(3)
Net Income (Loss)	1,371				1,371
Ending balance (in shares) at Sep. 30, 2024			76,027
Ending balance at Sep. 30, 2024	34,369		$ 76	223,389	(189,089)		(7)
Beginning balance (in shares) at Jun. 30, 2024			75,473
Beginning balance at Jun. 30, 2024	30,718		$ 75	221,612	(190,967)		(2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock resulting from the exercise of stock options (in shares)			511
Issuance of common stock resulting from the exercise of stock options	1,043		$ 1	1,042
Issuance of restricted stock (in shares)			43
Issuance of restricted stock	0
Share-based compensation	735			735
Translation adjustment	(5)						(5)
Net Income (Loss)	1,878				1,878
Ending balance (in shares) at Sep. 30, 2024			76,027
Ending balance at Sep. 30, 2024	$ 34,369		$ 76	$ 223,389	$ (189,089)		$ (7)